References
- Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003; 25: 2958–2971
- Hoerger TJ. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes. Med Care 2009; 47: S21–27
- Hunt J, Rozenfeld Y, Shenolikar R. Effect of patient medication cost share on adherence and glycemic control. Manag Care 2009; 18: 47–53
- Ly D, Alex FZ, Christopher H. Cost effectiveness analysis of a hypertension management program in patients with type 2 diabetes. J Clin Hypertens (Greenwich) 2009; 11: 116–124
- Goldfarb N, Weston C, Hartmann CW, et al. Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literature. Dis Manag 2004; 7: 61–75
- Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007; 298: 61–69
- Harrold LR, Andrade SE. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2009; 38: 396–402
- Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521–530
- McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868–2879
- Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005; 165: 1147–1152
- Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455–461
- Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005; 14: 789–793
- Duru OK, Schmittdiel JA, Dyer WT, et al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care 2010; 16: 33–40
- Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005–2012
- Kosanke J, Bergstralh EJ. gmatch SAS Macro. [SAS Macro] 2003 4/7/2004 [cited 2009 June 29]; Match 1 or more controls to cases using the GREEDY algorithm]. Available from: http://mayoresearch.mayo.edu/mayo/research/biostat/upload/gmatch.sas
- Perkins SM, Tu W, Underhill MG, et al. The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 2000; 9: 93–101
- D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–2281
- Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984; 79: 516–524
- Barron J, Wahl P, Fisher M, et al. Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications. P T 2008; 33: 532–553
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487–497
- Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245–1251
- Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care 2008; 14: 15–23
- Maddala GS. Limited-Dependent and Qualitative Variables in Econometrics. New York, NY: Cambridge University Press, 1983.
- (OHRP) OoHP. Basic HHS Policy for Protection of Human Research Subjects. In: Service HaH, ed. 2009.
- Adherence to Chronic Medications. NCQ# 0542: The National Quality Forum 2009.
- Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27: 2800–2805
- Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676–1685
- Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003; 26: 2300–2304